Article
Longitudinal visceral adipose heterogeneity supports digital health stratification of infliximab response loss in Crohn disease
2026-08-24
Abstract excerpt
<title>Abstract</title> <p>Secondary loss of response to infliximab is common in Crohn disease, but existing monitoring does not capture treatment-related changes in mesenteric adipose tissue. We developed a longitudinal computed tomography enterography-derived visceral adipose tissue heterogeneity score (VHS) and integrated its post-induction percentage change (%ΔVHS) with clinical disease behavior to stratify s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eac6da13-dde7-53a4-8015-b68624cb0bae
- DOI
- 10.21203/rs.3.rs-10658714/v1
